Frexalimab (anti-CD40L) is a monoclonal antibody targeting the CD40 ligand (CD40L). Frexalimab (anti-CD40L) has the potential for multiple sclerosis research.
Specification: Carrier Free, Recombinant, ExactAb™, Low Endotoxin, Azide Free, Validated, ≥95%(SDS-PAGE&SEC), Lot by Lot
Related Documents: https://ald-pub-files.oss-cn-shanghai.aliyuncs.com/aladdinsci/pdp/sds/1/AB182964-SCI_feb2a8f2189c673ecc0a2487f9a61024.pdf
- UPC:
- 51201900
- Condition:
- New
- Availability:
- 4-8 weeks
- Weight:
- 0.07 Ounces
- HazmatClass:
- No
- WeightUOM:
- LB
- MPN:
- Ab182964-10mg
- CAS:
- 2515463-86-0
- Product Size:
- 10mg